Eric J. Ende, Director at Matinas BioPharma Holdings, Inc. (MTNB), bought 20,000 shares at $0.68 ($14K) on 2019-08-19, disclosed to the SEC on 2019-08-21.
Open-market purchase of $14k MTNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| AVDL | BUY | 2022-11-23 | $156K | — | Filing → |
| AVDL | BUY | 2022-06-01 | $78K | — | Filing → |
| AVDL | BUY | 2022-05-31 | $37K | — | Filing → |